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Abstract
Background: The number of elderly patients that present with an acute coronary syndrome
(ACS) is increasing, reflecting the growing number of people in the general population in this
age group. The various guidelines do not generally specify a management strategy in this
elderly group and the management is often at the discretion of the treating physician. We
conducted an audit within our Cardiology Department to compare our practice of management
of ACS in the elderly population based on the European Society of Cardiology guidelines.
Methods: We conducted a retrospective analysis of the management of patients aged 80 and
above that were admitted with troponin positive chest pain from 1st January to 31st December 2010.
Patient information was primarily obtained from our computer data base system that includes
blood results, ECHOs, diagnostic angiograms, discharge and clinic letters. If the information
was inadequate we obtained patient files or contacted the relevant general practitioner.
Results: Octo-nonagenarians represented just over a third (35%) of all patients that were
admitted with a troponin positive event during the study period. We noted a 10% mortality rate
observed in our study population over a 12 month period. Atrial fibrillation was an incidental
finding in 22% of patients. Nearly half of these patients (49%) were managed by the
cardiologists. 68% of these patients underwent diagnostic coronary angiography, of which 32%
went on to have percutaneous coronary intervention and 7% underwent surgical intervention.
Majority (80%) of patients that underwent angioplasty had more than 1 stent and 74% of
patients required more than one coronary vessel to be stented. The length of stay in hospital
was double for patients who were under the care of the general medical teams rather than the
cardiology team. This group also had a higher number of other comorbidities such as dementia,
malignancy, a history of gastro intestinal bleeds and chronic renal impairment.
Conclusions: Octo and nonagenarians represent a significant proportion of our ACS patients.
They have high mortality, greater number of comorbidities, diseased coronary vessels and if
intervention was undertaken required more than one stent. Therefore, octo-nonagenarians
represent a very complex group of patients. Guidelines and risk stratification are of limited
value in this group as clinical trial data is currently lacking. Quality of life and risk to benefit
assessments are of paramount importance in this group. (Cardiol J 2012; 19, 4: 395–401)
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Introduction
The population dynamics of the UK are chang-
ing. The last 25 years has seen an increase in the
number of people above the age of 65 by 1.7 million
[1]. If we look at projected forecasts to 2034 then
23% of our population will be 65 or above [1]. Per-
haps what is even more surprising is that the fast-
est population increase has been in the number of
those aged 85 and over. In 1984, there were around
660,000 people in the UK aged 85 and over, by 2009
this had doubled to 1.4 million. Forecast projections
put the number of this age group at 3.5 million or
5% of the UK population by 2034 [2]. The trend is
also being replicated in Europe and United States [3].
In fact, the growth of the octogenarian population is
estimated to triple by 2050 across Europe [1].
Heart disease remains the leading cause of
death for both men and women of all ages [4]. This
population shift will obviously have implications on
health budgets. For example, patients aged 75 and
older represent one third of those hospitalized with
acute ischemic events and account for more than
half of all cardiac deaths [5]. Patients over 75 years
of age have twice the mortality rates than patients
below 75 years of age [6]. Age has now been reco-
gnized as one of the most important risk predictors
in patients admitted with a non-ST elevation myo-
cardial infarction (NSTEMI) [7]. However due to
lack of data on the management of acute coronary
syndromes (ACS) in this age group some ambigu-
ity remains in evidence based treatment of octoge-
narians. The current guidelines from the European
Society of Cardiology strongly advice to take into
consideration estimated life expectancy, co-morbidi-
ties and quality of life prior to any decisions in the
management of our older NSTEMI patients [6].
We conducted an audit to investigate the man-
agement of patients aged 80 and above, who were
admitted to our institution with a diagnosis of ei-
ther ST elevation myocardial infarction (STEMI) or
a NSTEMI or NSTE-ACS and compared our prac-
tice to the recommended guidelines for manage-
ment of these conditions.
Methods
We conducted a retrospective analysis of the
management of patients aged 80 and above that
were admitted with troponin positive chest pain
during 2010. These patients were either treated as
STEMI or as NSTEMI. The list of troponin posi-
tive patients admitted between the 1st of January
2010 and the 31st of December 2010 was obtained
from our medical records department. This list was
further cross checked with the MINAP database and
the clinical governance department. We then sepa-
rated patient’s that were 80 or above into our study
group. Patient information thereafter was primarily
obtained from our computer data base system that
includes blood results, ECHOs, diagnostic angio-
grams, discharge and clinic letters. If the informa-
tion was inadequate we obtained patient files or con-
tacted the relevant general practitioner. This audit
has been registered with our audit department.
Results
There were a total of 510 patients who were
admitted with a diagnosis of a myocardial infarction
(MI) (either STEMI or NSTEMI) to Good Hope
Hospital during the period from 1st January 2010 to
31st December 2010. Of these, 177 were above the
age of 80 representing 35% of the patients with an
ACS. The male to female ratio was almost equally
split at 49.7% and 50.3%, respectively. The mean
and median ages were 86.2 and 86 years respective-
ly (Fig. 1).
Table 1 summarizes the past medical history
of these patients. Interestingly, more than half of
the patients had no previous history of diabetes
mellitus, MI, percutaneous coronary intervention
(PCI) or coronary artery bypass grafts (CABG).
However 78% had hypertension and 48% had pre-
vious strokes. There was also a higher prevalence
of other co-morbidities (Table 1), including demen-
tia (21%), malignancy (13%), previous gastro intes-
tinal bleed (5%) and chronic renal impairment
(12%). Figure 2 demonstrates the range of comor-
bidities that were present, with only 10 (6%) pa-
tients having no comorbidities, whilst 4 (2%) pa-
tients had more than 7. We also found that 106
(61%) and 8 (4%) of our patients were ex-smokers
or continued to smoke respectively.
The majority of patients presented with the
only symptom being chest pain (80%). However
a further 15% had presented with chest pain along
with another symptom (Table 2). The remaining 5%
of patients denied any chest pain and presented with
other complaints, the reasons for performing tropo-
nin levels were not made clear. It was considered
to be an incidental finding as the patients had pre-
sented with totally non cardiac symptoms and the
troponin was sent as part of routine testing. These
patients were therefore excluded from the analysis.
22% (39 patients) of the patients in our study
were found to be in atrial fibrillation (AF) on admis-
sion. Only 2 out of the 39 patients had complained
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of palpitations as the presenting complaint. There-
fore AF was an incidental finding in 37 patients.
Of the total 177 patients, 86 were transferred
under the care of the cardiology team with the re-
maining 91 staying under the care of the general
medical team. Of the 91 patients that remained
under the care of the general medical teams 21
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Figure 1. Age distribution of the population.
Table 1. Past medical history of significant risk
factors.
Yes (%)
Previous MI 70 (40%)
Previous PCI 12 (7%)
Previous CABG 11 (6%)
Diabetes mellitus 51 (29%)
Hypertension 138 (78%)
Stroke 43 (24%)
Dementia 23 (21%)
Arthritis 4 (4%)
Chronic kidney disease 12 (11%)
Hypothyroidism 8 (7%)
Osteoarthritis 15 (14%)
Glaucoma 4 (4%)
Chronic obstructive airway 16 (15%)
disease/asthma
Malignancy 14 (13%)
Peripheral vascular disease 6 (5%)
Gastro intestinal bleeds 6 (5%)
Unknown 6 (5%)
MI — myocardial infarction; PCI — percutaneous coronary intervention;
CABG — coronary artery bypass graft
Figure 2. Distribution of the number of comorbidities
among the study group.
Table 2. Presenting complaint in the patient group.
Presenting complaints Number (%)
Chest pain only 140 (80%)
Chest pain with respiratory infection 5 (3%)
Chest pain with urosepsis 2 (1%)
Chest pain and falls 3 (2%)
Chest pain and breathlessness 10 (6%)
Chest pain and dizzy 2 (1%)
Chest pain confusion 1 (< 1%)
Incidental finding of a raised troponin 9 (5%)
Chest pain with palpitation 3 (2%)
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(23%) were discussed with the cardiologist. The
most common reason for the cardiology team not
accepting a patient or for the medical team not re-
ferring patients to the cardiologist was the presence
of significant comorbidities such as dementia or
advanced malignancy (89%). Two patients had re-
quested medical management and another 5 pa-
tients had sepsis.
We found that 59 of the 86 (69%) patients that
were admitted or transferred under cardiology care
had diagnostic angiography. The reasons for not
performing angiography on the remaining 27 pa-
tients are listed in Figure 3. The commonest rea-
son for 32% or 10 patients was for a trial of medical
therapy in the first instance with a view to take
a more invasive approach if that failed. In 4 (15%)
patients of patients no clear explanation was docu-
mented as to why diagnostic coronary angiography
was not performed (Fig. 3).
Of the 59 patients that underwent diagnostic
angiography 34 (58%) patients were for medical
management. 32 of these patients had no flow lim-
iting disease, described as less than 75% stenosis,
therefore not requiring intervention. The remain-
ing 2 patients were deemed to be too frail for any
intervention as they had extensive coronary artery
disease. It is therefore not clear why they under-
went any invasive test in the first place.
Out of the 25 patients with significant disease
demonstrated on diagnostic coronary angiography,
19 had PCI, 4 had CABG but 2 patients opted for
medical management only. The frequency of the
coronary vessels stented were 5 (16%), 9 (30%),
8 (27%) and 8 (27%) for left main stem, left anteri-
or descending, circumflex (including obtuse marginal)
and right coronary, respectively. The frequency of
single, double, triple and quadruple stents implant-
ed were 4 (23%), 7 (37%), 5 (26%) and 3 (18%) re-
spectively. Therefore in summary, of the 19 patients
that underwent PCI, 15 (75%) required more than
1 stent and 15 (75%) required more than 1 coro-
nary artery to be stented with nearly half of the
patients requiring stenting of either the left main
or the left anterior descending artery.
We compared patient length of in-hospital stay
depending on whether they were under the general
medical or cardiology team (Fig. 4). We found that
the length of stay under the cardiologists was less.
The mean/median lengths of stay under cardiology
department and general medical departments were
5.9/5 and 10.4/10 days, respectively. 61% of patients
under the cardiologists were discharged within
5 days whereas only 32% of the patients under the
medical team were discharge within this time frame.
During the following year, we found that 17
(10%) patients of study population died. Six patients
had out of hospital cardiac arrests and were not re-
vived. The remaining 11 patients died whilst as in-
patients. Nine of these patients died within 24 h
from cardiogenic shock or aspirational pneumonia,
7 of these 9 patients were discussed with the car-
diology team and were for medical/palliative treat-
ment only. Out of the remaining 2 patients, both had
prolonged admissions, ultimately dying from bron-
chopneumonia. No deaths were reported whilst
under the care of the cardiology team
Eight patients died before being seen in the
follow up clinic, 2 from cardiac causes and 6 non
Figure 3. Explanation for patients under cardiology not
undergoing diagnostic angiography.
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cardiac causes. Of the 19 patients that had PCI
18 were alive at 12 months, 1 patient had died from
a non-cardiac cause, 2 patients had recurrence of
their symptoms of which 1 patient had a further
NSTEMI. However both had repeat diagnostic
angiogram with patent stents and without flow lim-
iting disease.
All patients that had CABG were followed up
and were alive at 12 months.
Discussion
Recent Myocardial infarction National Audit
Project (MINAP) data noted the average age of pa-
tients with NSTEMI was 70 years of age and for first
presentation STEMI was 65 years of age, with 52%
of all myocardial infarcts occurring in patients aged
70 or above [8]. Taking into account European re-
gistries 27–34% of NSTEMI patients were 75 years
or over [9, 10], however less than 20% of patients
aged 75 years or more were included in clinical tri-
als [11]. This has led to some ambiguity in the treat-
ment of octogenarians with ACS and therefore age
dependent inequalities in the management of these
patients [12]. Despite this, significant reduction in
hospital mortality of ACS patients in England and
Wales has been seen across all age groups [12].
The management of elderly patients with an
ACS is challenging. The risk of complications of an
invasive strategy is high in this population group
[13, 14], however these high risk patients are of-
ten those with the most to gain [15–19]. With the
ageing population the decision whether to medically
manage or subject patients to an interventional pro-
cedure are a common clinical dilemma.
In our study we found that around one-third of
patients who were admitted with an ACS were
above the age of 80. This is in keeping with other
studies [5]. Around half of the patients who were
admitted, however remained under the admitting
medical team with 70 of the total 177 (39%) not even
being discussed with the cardiology team. This is
potentially a contentious point — whether the de-
cision to investigate these patients further should
be taken in conjunction with the cardiologists or
whether the admitting medical team could make the
decision. Currently there are no national or inter-
national guideline recommendations on who makes
the decision. The ESC guidelines only recommend
that any decision should be based on individual eld-
erly patients, taking into account, “ischemic and
bleeding risk, estimated life expectancy, co-morbi-
dities, quality of life, patient wishes, and the esti-
mated risks and benefits of revascularization” [6].
Only a third of our study group had an angio-
gram. It is not clear from the records whether the
decision not to have any invasive testing was tak-
en in conjunction with the patient or whether it was
a medical decision. It was clearly documented only
in 6 patients that the patient did not wish to have
any invasive investigation done. Similarly in about
10 patients who were under the cardiologists, the
plan was for medical therapy in the first instance,
with a view to invasive testing if the patient failed
medical therapy. This is debatable, as clinical evi-
dence suggests that in the setting of an ACS, an
early invasive strategy is far superior to a conser-
vative strategy [12, 13]. Although not documented
in the medical notes, it is possible that these pa-
tients either had significant co-morbidities or were
physically frail or had other reasons for the treat-
ing clinician to make that decision. However this
was not clear from the medical notes.
There was an overall mortality rate of 17 (10%)
patients in our octo-nonagenarians group. Six were
out patient cardiac arrests that could not be resus-
citated, the remaining 11 patients died during their
stay in hospital. The majority (9 of the 11) died with-
in 24 h from cardiogenic shock. The remaining
2 died after a prolonged in patient stay in hospital
with bronchopneumonia. These 2 patients had
a number of comorbidities including dementia.
Patients with the greater number of comorbid-
ities remained under the care of the medical teams
and as mentioned above had no cardiac interven-
tion. These are also the patients not surprisingly
who had a longer length of stay. Within this con-
text great care needs to be exercised and to ensure
that all suitable patients are at least considered for
intervention if required. This has been highlighted
in some studies that found patients admitted with
NSTEMI had lower mortality if under cardiac care
than general medical care [20, 21]. These studies
included all ages and not only octogenarians.
Patient comorbidities are a very important and
integral part of the decision making process in the
elderly. 94% of our patients had at least a 1 signifi-
cant comorbidity, with 21% and 5% having a histo-
ry of dementia and gastrointestinal bleeding respec-
tively. Informed consent and the reasons for per-
forming an invasive procedure that has an
associated complication risk must be clearly ex-
plained with simple grammar and highlighting im-
portant points [22, 23]. We found that 22% of pa-
tients that did not have diagnostic angiograms didn’t
have it done at their own request. If a decision not
to pursue an invasive procedure is made, then clear
documentation of the reason must always be made.
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If however patients agree to undergo intervention
then stressing the importance of post-procedural
compliance of any treatment is associated with im-
proved patient outcomes [24, 25].
In our study 39 (22%) of the patients were found
to be in AF on admission. However, only 2 out of the
39 patients had complained of palpitations as the
presenting complaint. Therefore AF was an inciden-
tal finding in 37 patients as mentioned within the
results. The prevalence of AF in octogenarians has
been quoted as 5–15% [26]. Our results seem to
suggest that ischemia could be the cause of AF in
this patient group; however our numbers were too
small to make such conclusions.
Elderly patients are often more passive and
have a more accepting manner than younger pa-
tients [27–29]. More recently, this tide is turning
with an increase in operative details being request-
ed in all patients, however the greatest increase has
been seen in the elderly [30]. If doubt remains about
capacity, the patient’s ability to retain and effective-
ly communicate the risks and benefits of the intend-
ed procedure together the decision regarding the
procedure should be assessed [31]. A relatively
quick and straightforward test of cognition, the
mini-mental state examination, should be carried
out [32, 33].
Review of literature reveals that PCI procedur-
al complication rates were higher in the elderly age
group. However this was counter balanced with
fewer hospital admissions and improved quality of
life [16, 19, 34–36]. We also observed a positive
effect after intervention in our patient group. Out
of 19 patients that had PCI, 17 had no hospital ad-
missions for angina over 12 months. The 2 patients
that were readmitted had repeat angiography that
failed to demonstrate any significant stenosis. Sim-
ilarly, all 4 patients that had undergone CABG were
symptom free for 12 months following surgery. This
is in keeping with another retrospective study that
has shown that the 30 day and 12 month mortality
between octogenarians undergoing PCI or CABG
is similar [34]. However, this data is biased as this
is non-randomized with only the older patients with
the least comorbidities were put forward for inter-
vention. This does however highlight the fact that
patient selection is very important in this age group
and that a decision to intervene or not should be
made on a case by case basis, taking into consider-
ation the co-morbidities and the physical wellbeing,
rather than on age alone.
This study is a retrospective audit of the mana-
gement of elderly patients with a NSTEMI in our
institution. It is therefore a purely observational
study. In addition, all the information was obtained
from the patient case notes and in some instances
from the patient’s general practitioner. Retrospec-
tive analysis of case notes has its limitations as the
quality of data is related to the quality of case note
documentation, which occasionally may be less than
satisfactory. Another drawback of our study was the
fact that we did not have many patients with STEMI
in our study group. This is because all patients with
STEMI are transferred directly to our regional in-
terventional centre and do not come to our hospital.
Conclusions
Octo and nonagenarians represent a significant
number of our ACS patients. They also represent
a very complex group of patients as there are many
other non-medical and medical issues that often
make decision making difficult. Guidelines and risk
stratification are of limited value in this group as
clinical trial data is lacking. Therefore good com-
munication between general medical and cardiolo-
gy teams are essential in management of older pa-
tients. All patients including older patients should
be presented with the various treatment options,
and their views should be taken into consideration
when making the decision whether or not to offer
them invasive treatment strategies. Quality of life,
and risk benefit assessments are of pivotal impor-
tance in our octo and nonagenarians.
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